Subject: MSG A Must read (Very interesting)

THE HEALTH HAZARDS OF OMNIPRESENT MSG
The Shocking Dangers of MSG You Don't Know


---

Study: Flame Retardant, PBED  linked to hyperthyroidism in cats, scientific study by the EPA noted a possible connection  to flame retardants used on new mattresses, furniture cushions electronics and carpet padding, in household dust and some pet foods.They have found PBDE  mimic thyroid hormones causing the hyperthyroidism illness in cats (Dr. Dodd's comment isn't the EPA interested in what this PBDE is doing to infants sleeping on such mattresses and toddlers crawling on carpets )

---

This is why I say "Don't Trust Any Man's sauce," Always detox everything you put into your mouth and your animal's mouth on my blue green detox papers. We can' even trust organic foods and even organic lettuce , for heaven's sake.
1. http://articles.mercola.com/sites/articles/archive/2007/07/13/are-there-antibiotics-in-your-lettuce.aspx
2. http://articles.mercola.com/sites/articles/archive/2007/08/01/genetically-modified-organisms-are-a-looming-threat.aspx

---

How Much They Spray
http://www.alternatives2toxics.org/catsoldsite/how_much.htm

---

CANCER: PROOF OF CARCINOGENIC EFFECTS OF MINISCULE AMOUNTS OF CARCINOGENS IN OUR ENVIRONMENT TO MAN AND ANIMAL
CANCER: HOW DANGEROUS ARE OUR COSMETICS?
By Devra Davis - Special to Newsweek - February 15, 2007

http://www.msnbc.msn.com/id/17177813/site/newsweek/


---

Finally We Know Why Cooking Grains Can Poison Your Food
http://www.mercola.com/2006/dec/12/finally-we-know-why-cooking-grains-can-poison-your-food.htm

---

TAMIFLU WARNING
WASHINGTON (AP) More than 100 recent cases of delirium, hallucinations and other unusual psychiatric behavior in Japanese patients treated with Tamiflu should have parents watching for similar reactions when treating their children with the flu drug.

That's the new advice from the Food and Drug Administration in adding a new precaution to the label of the influenza drug, prescribed about 2 million times a year in the United States. The FDA updated the label after receiving the 103 reports of abnormal behavior, most of which involved children in Japan. Japan uses more Tamiflu than any other country in the world, with more than 30 million prescriptions since 2001. It's been prescribed about 8 million times in the U.S. since 1999. The FDA said a relationship between the drug and the behavior had not been established and that the updated label was "intended to mitigate a potential risk associated with Tamiflu." It recommends that close monitoring of patients begin immediately after starting treatment with the drug.

The changes bring the U.S. label more in line with the Japanese one, which already warned that such abnormal behavior could occur. The previous FDA-approved label mentioned only that "seizure and confusion" had been seen in some patients Tamiflu is made by the Swiss pharmaceutical company Roche Holding AG. Roche.

Spokesman Terence Hurley said there was no evidence the drug caused the rarely occurring adverse events. Both Roche and the FDA also said that severe cases of the flu can spark the abnormal behavior flagged in the updated label. Furthermore, the FDA acknowledged that stopping treatment with Tamiflu could actually harm influenza patients if the virus is the cause of delirium, hallucinations and other abnormal behavior, such as aggression and suicidal thoughts. Health officials have been sensitive about taking any action that might dissuade people from taking Tamiflu, since the drug could play an important role in an outbreak of bird flu. The drug doesn't prevent flu but can reduce the length and severity of its symptoms.

Previously, Roche has cited studies from the United States and Canada that show the death rate of influenza patients who took Tamiflu was far below the dosewho did not. Still, the number of reports of bizarre behavior is increasing.
The 103 new cases occurred between Aug. 29, 2005, and July 6, 2006. The tally marks a sharp increase when compared with the 126 similar cases logged over more than five years between the drug's approval in 1999 and August 2005, the FDA said.

Even though severe cases of the flu can spark abnormal behavior, the number and nature of the newly reported cases along with comments from doctors who believe the behavior was associated with the drug keep the FDA from ruling
out Tamiflu as the cause, the agency said. Tamiflu is one of the few drugs believed effective in treating bird flu,
which health officials fear could spark a pandemic should it mutate into a form easily passed from human to human.
According to the label, Tamiflu is for the treatment of uncomplicated acute illness due to flu in patients 1 year and older, who have shown symptoms for no more than two days.


---

Virtually All Modern Disease Is Caused By "Metabolic Disruptors" Found In Everyday Foods And Groceries...
http://www.truthpublishing.com/GroceryWarning.html

---

Throw Away Your Dangerous Microwave Oven Now! Here are the dangers to your food
http://www.mercola.com/forms/turbo_oven.htm   

---

Toxicity from Teflon Coating  Cookware, Teflon may be convientient but it is poisoning you and your family ( and pet). See info at:
http://www.mercola.com/2005/jun/7/teflon_toxicity.htm, http://www.mercola.com/2005/jul/23/mercury_vaccines.htm


---

Swiffer Wetjet toxic for DOGS!!!

Subject: Warning for animals!! Swiffer Wetjet toxic! 
Warning for your animal's health: 
 
I recently had a neighbor who had to have their 5-year old German  Shepherd dog put down due to liver failure.  The dog was completely healthy until a few weeks ago, so they had a necropsy done to see what the cause was.  The liver levels were unbelievable, as if the   dog had ingested poison of some kind.  The dog is kept inside, and  when he's outside, someone's with him, so the idea of him getting into something unknown was hard to believe. My neighbor started going through all the items in the house.  When he got to the Swiffer Wetjet, he noticed, in very tiny print, a warning which stated "may be harmful to small children and animals."  He called the company to ask what the contents of the cleaning agent are and was astounded to find out that anitfreeze is one of the ingredients.  (actually he was told it's a compound which is one molecule away from anitfreeze).  Therefore, just by the dog walking on the floor cleaned with the solution, then licking it's own paws, and the dog eating from its dishes which were kept on the kitchen floor cleaned with this product, it ingested enough of the solution to destroy its liver. Soon after his dog's death, his housekeepers' two cats also died of liver failure.  They both used the Swiffer Wetjet for quick cleanups on their floors.  Necropsies weren't done on the cats, so they couldn't file a lawsuit, but he asked that we spread the word to as many people as possible so they don't lose their animals.

"Dr. Dodd's comments: altho this published article was proven to be a hoax, several of my colleages have had cases of dogs and cats suddenly developing liver and kidney failure after one change in household environment, the use of this product. Since the active ingredient in Swiffer wet jet is one molecule difference from Anti Freeze ( which is
one of the most poisonous substances known to animals and small children), I like to err on the side of caution and included this alert with urging people to stick to good old natural cleaning products of soap and water, baking soda and lemon juice."

---

Rimadyl: Most Arthritic Dogs Do Very Well On This Pill, Except Ones That Die
Wall Street Journal Staff Reporter - March 2000 - Chris Adams

You might call it a made-for-TV drug. Approved for human use in the U.S. but not marketed that way, an arthritis medicine called Rimadyl languished for nearly 10 years in developmental limbo, then emerged in a surprising new form. Instead of a human drug, it was now a drug for arthritic dogs. And it became a hit. With the aid of slick commercials featuring once-lame dogs bounding happily about, Rimadyl changed the way veterinarians treated dogs. Clients would walk in and say, 'What about this Rimadyl?' " says George Siemering, who practices in Springfield, VA.

Today, those TV spots are gone. The reason has to do with dogs like Montana. A six-year-old Siberian husky with stiff back legs, Montana hobbled out of a vet's office in Brooklyn, N.Y., six months ago accompanied by his human, Angela Giglio, and a supply of Rimadyl pills. At first, the drug appeared to work. But then Montana lost his appetite. He went limp, wobbling instead of walking. Finally he didn't walk at all. He ate leaves, vomited and had seizures and, eventually was put to sleep. An autopsy showed the sort of liver damage associated with a bad drug reaction. Pet drugs are big business; an estimated $3 billion world-wide and Rimadyl is one of the bestsellers. It has been given to more than four million dogs in the U.S. and more abroad, brought Pfizer Inc. tens of millions of dollars in sales, and pleased many veterinarians and dog owners.

But the drug has also stirred a controversy, with other pet owners complaining that nobody warned them of its risks. Montana's owner, Ms. Giglio, is among them. After she informed Pfizer and the Food and Drug Administration of her relatively youthful dog's death, Pfizer offered her $440 "as a gesture of good will" and to cover part of the medical costs. Insulted by the offer and a stipulation that she agree to tell no one about the payment except her tax preparers she refused to sign and didn't take the money. "There's just no way in my conscience or heart I can release them from blame," she says.

After reports of bad reactions and deaths started streaming in to the FDA, the agency suggested that Pfizer mention "death" as a possible side effect in a warning letter to vets, on labels and in TV ads. Pfizer eventually did use the word with vets and on labels, but when given an ultimatum about the commercials mention "death" in the audio or end the ads -- Pfizer chose to drop them. Pfizer's director of animal-products technical services, Edward W. Kanara, says that when reports started coming in, "we acted extremely promptly based on the information we had." Pfizer points out that reported adverse events involve less than 1% of treated dogs. Since Rimadyl's 1997 launch, the FDA has received reports of about 1,000 dogs that died or were put to sleep and 7,000 more that had bad reactions after taking the drug, records and official estimates indicate. The FDA says such events are significantly underreported. While the numbers include cases "possibly" related to Rimadyl, it is hard to be sure. Many dogs given the arthritis drug are older, and few are autopsied after they die. Pfizer says it analyzed cases of Rimadyl-treated dogs that died in 1998 and found a link to Rimadyl to be "likely" in 12% of cases and "not likely" in 22%; it says there was too little information for a judgment about the others.

Still Approved
Despite these problems, the FDA says Rimadyl deserves to be on the market, provided vets take the proper precautions. These include advising-dog owners what bad reactions to watch for and periodically doing liver-function or other lab tests. Within a few weeks, Pfizer will begin affixing a safety sheet directly to packages of Rimadyl pills. It is the first time either FDA officials or Pfizer can recall such a step being taken in the world of animal drugs. Rimadyl, generically carprofen, is an anti-inflammatory medicine. Developer Roche Laboratories expected to market it for people in 1988 and received FDA approval, but shelved the plan after concluding the market for such drugs was too crowded. In addition, some outside experts expressed concerns; a commentary in a pharmaceutical journal noted unusual liver-function readings in 14% to 20% of test subjects and opined that "until additional data on carprofen are available, older compounds should probably be tried initially." The idea of switching the product to the animal-drug track soon arose. A couple of corporate transactions later, it ended up in the hands of Pfizer's animal-drug unit.

There, it was treated to the kind of sophisticated marketing Pfizer does well. A survey of 885 dog owners was done. Besides shedding light on favorite dog names (Jake, Ginger, Lady), the poll revealed that one-fifth of dog owners would be willing to spend "whatever it took" to buy an aging dog an extra year or two of life. No fewer than 53% agreed that "my dog is a better companion than other members of my family." The FDA requires safety and efficacy testing for animal drugs just as for human ones, but animal-drug tests are smaller. Pfizer says about 500 dogs got Rimadyl in various trials, which is no more than a fifth of the number of subjects in comparable human-drug trials. Some dogs showed unusual liver-function readings and one young beagle on a high dose died, but for the most part, the FDA and Pfizer didn't find side effects alarming. The drug was approved for an early-1997 launch. That same year, the FDA made it easier to market drugs directly to consumers on TV. Soon, Pfizer was running commercials in which a once stiff yellow Labrador retriever named Lady bounded over a fallen tree as she fetched tennis balls beside a lake. In another ad, a dog leapt through a window and slid down a banister. There were also full-page magazine ads and a public-relations campaign, whose results, the PR firm later said, included 1,785 print stories, 856 radio reports and 245 TV news reports "generating 25.5 million positive impressions on the product."

Early on, vets were floored by the drug's effects. "The results in some cases have been pretty darn close to miraculous," says David Whitten of the Hilldale Veterinary Hospital in Southfield, Mich. "I'm using this drug on my own dog. It has been effective but as with all medications, side effects are certainly a problem."

The First Complaints
Indeed, within months of the launch, vets at Colorado State University in Fort Collins noticed troubling reactions. Labrador retrievers seemed particularly affected. Since the safety studies for Rimadyl had emphasized testing on young beagles, Pfizer went back to conduct another, small test just on Labs; it says that test showed no particular problem. Bill Keller, an FDA veterinary-medicine official, notes that "any time you take a product from the investigation and put it into actual practice, you're going to see things you didn't expect." But reports about Rimadyl came in by the hundreds. The FDA had received just over 3,000 animal-drug bad-reaction reports in 1996, the year before Rimadyl's launch; in 1998, the drug's first full year, Rimadyl alone produced more than that many. They swamped the FDA's tiny Center for Veterinary Medicine in Rockville, Md. Pfizer was scrambling as well. "Basically, their response," says Dr. Keller, "was 'Tell us what you want us to do. We love the fact that it's selling so well, but we don't know what to do with all these adverse reactions.' "

The FDA and Pfizer discussed a "Dear Doctor" letter to be sent to vets. FDA records show the agency found parts of an early Pfizer draft "unacceptable as they are promotional in tone... ." It was revised. The records also show Pfizer disagreed with the FDA's suggestion that the letter cite "death" as a possible side effect. To get the letter out, the FDA told Pfizer it was "agreeing to your exclusion of the 'death' syndrome from the letter at this time. However, we will revisit the 'death' syndrome issue and other potential side effects for possible inclusion in labeling at a later date." So the term didn't appear in the first warning Pfizer sent, in mid-1997.

Clear Benefits
Meanwhile, dog owners were asking for Rimadyl. "It was their advertising that sold me on the drug," says Michelle Walsh, a Phoenix woman who says her miniature schnauzer was given it and later died. Not that vets needed much convincing. They saw clear benefits from the drug. On top of that, they could get points from Pfizer for each Rimadyl purchase they made; points were redeemable for PaImPilots, Zip drives for PCs and other equipment.

Although Pfizer's letter told vets to explain to owners the signs of a bad reaction to Rimadyl, such as vomiting, lethargy or diarrhea, it is evident that a great many didn't. The FDA's Dr. Keller says, "There are a lot of veterinarians who don't think they need to take the time, or who forget, or for whatever reason are not providing animal owners with this information."

Donna Allen, whose chow-mix, Maggie, started on Rimadyl last summer, says, "All my vet did was give me this little bag of pills, with no information." She says Maggie "didn't want to take it, but I made her." After four weeks, Maggie began to vomit violently, Ms. Allen says. The dog vanished from their home outside Birmingham, Ala., and later was found lying in a ditch. Ms. Allen loaded her into a truck and sped 35 miles to a veterinary clinic, but the five-year-old dog died. Her vet wouldn't implicate Rimadyl in the death until Ms. Allen urged him to send the dog's internal organs to the University of Illinois vet school, where an examination showed liver toxicity. Maggie was buried under a marker adorned with the figure of an angel. And Ms. Allen took to the streets, delivering a letter to all the vets in the area urging them to "understand that Rimadyl helps certain dogs, but it is poison to other dogs."

The D-Word
As the complaints poured in, the FDA told Pfizer it would have to revisit the label issue. Pfizer had referred to "fatal outcomes" on the label as a possible effect of the drug class to which Rimadyl belonged, but not specifically of this drug. Now the agency asked that Pfizer cite "death" prominently as a possible side effect of the drug. Describing the back and forth with Pfizer, the FDA's Dr. Keller says, "They did it. They weren't enthusiastic about it, but they have always been cooperative. And that's part of the nature of the game we play with industry." But the FDA also wanted the word "death" in the audio of commercials. Pfizer indicated this "would be devastating to the product," FDA minutes of a February 1999 meeting show. A company spokesman says that "putting 'death' on a 30-second commercial and in proper context was something we didn't think was possible." Rather than do so, it eventually pulled the commercials.

Pfizer says it now will do traditional marketing to vets, making sure they know the proper way to use the drug. Another "Dear Doctor" letter will soon go out, and the company will start attaching a safety sheet to pill packages.

Pfizer acknowledges it has a perception problem with some dog owners; a consumer group, for instance, has mounted a campaign dubbed BARKS, for Be Aware of Rimadyl's Known Side-effects. The company is contacting dog owners who have told their stories on the Internet, and it is offering to pay medical and diagnostic expenses for some dogs who may have been harmed by Rimadyl.

But Pfizer stands firmly behind the value of the drug, of which it says sales have continued to grow. Most vets also remain strongly behind Rimadyl. Owners, too, generally say they think the drug is important -- they just want to know the risks. Atlantan Roger Williams gave his mixed-breed terrier, William, Rimadyl for more than a year and believes it contributed to the dog's death. "But if I had to do it all over, I would give my dog Rimadyl again," he says. "The difference is I would have known what to expect. Without Rimadyl, William was miserable. And what's the point of living another three years if you're miserable?"

Dr. Dodd's comment:"There is no reason why any animal should be subjected to the possibility of death and suffering from drugs like Rimadyl , when there are homeopathic remedies, acupuncture, Vit C and Vit E supplementation that can make a severely arthritic animal pain- free and mobile again."


---

DIOXIN in PLASTIC WARNING

Some info you might find interesting. Johns Hopkins has recently sent this out in their newsletters...worth noting... Dioxin Carcinogens causes cancer. Especially breast cancer. Don't freeze your plastic water bottles with water as this also releases dioxin in the plastic.

Dr. Edward Fujimoto from Castle hospital was on a TV program explaining this health hazard. (He is the manager of the Wellness Program at the hospital.) He was talking about dioxin and how bad they are for us. He said that we should not be heating our food in the microwave using plastic containers.

This applies to foods that contain fat. He said that the combination of fat, high heat and plastics releases dioxin into the food and ultimately into the cells of the body.

Dioxin are carcinogens and highly toxic to the cells of our bodies. Instead, he recommends using glass, Corning Ware, or ceramic containers for heating food. You get the same results .without the dioxin.

So such things as TV dinners, instant ramen and soups ,etc., should be removed from the container and heated in something else. Paper isn't bad but you don't know what is in the paper. Just safer to use tempered glass, Corning Ware, etc. He said we might remember when some of the fast food restaurants moved away from the foam containers to paper. The dioxin problem is one of the reasons. To add to this: Saran wrap placed over foods as they are nuked, with the high heat, actually drips poisonous toxins into the food, use paper towels.New Heartworm Prevention Drug Warning

---

New Heartworm Prevention Drug Warning

Dr. Dodd’s Comment: Wouldn’t it be much easier, less expensive and a whole lot SAFER to stop giving dangerous drugs as parasite prevention and build a healthy body to withstand parasites? This is what I am dedicated to pass on to the public with this website. See new article on PARASITES I’ve written,(click on Disease Medicine link).

This alert was published in VETMED:

“I don't know how many of you use this product, but you might want tore-think this. This is definitely *not* a hoax - I have been following this story for sometime, ever since techs at my own vet's clinic told me they had 3 dogs die from it within a 6-week period.” Pat Miller.

Heartworm Medicine Linked To Sickness, Death
FDA Receives More Than 5,000 Adverse Reaction Reports
POSTED: 3:21 pm CDT May 25, 2004

A new heartworm medication called ProHeart 6 has been linked to a number of dog deaths, an NBC 5 investigation finds.Since it was approved in May 2001, the U.S. Food and Drug Administration has received more than 5,000 reports of adverse reactions -- 491 of them deaths.Now, the FDA is investigating. Debra McMullen has other dogs now, but says none can take the place of Sassy, the Chihuahua who moved across the country with her."She was my baby. I don't have children, so she was my baby," McMullen said. After using monthly heartworm prevention tablets she sometimes forgot, McMullen asked her veterinarian about the six-month injection called ProHeart 6. She wondered if her 11-year-old dog was too old."And he said, 'No, that shouldn't matter. She's fine.' And he gave her the shot and the very next day she started having breathing problems," McMullen said. Two weeks later, Sassy was dead.

Chief was dead just days after his only ProHeart 6 injection, according to his owner. Eric Williams raised the 9-year-old Rottweiler from a pup."For a completely healthy dog, in the space of three or four days, to go through what I saw Chief go through is not right," Williams said.

Canine Heartworm Medication Adverse Reaction Comparisons
(Source, FDA, As of 5/03/2004)
Drug Total Adverse Reactions Total DeathsYear ApprovedAvg. ReactionsAvg.
Deaths From ProHeart 6
(Moxidectin):449941520011500 138 Injection
Revolution
(Selamectin):86951811999173736 Topical
Interceptor
(Milbemycine oxime):19228419952149 Oral
Heartguard
(Ivermectin/Pyrantel):2840511996355 6 Oral
Sentinel
(Milbemycine oxide/luferon):8922519992336 Oral

FDA figures show the number of ProHeart 6 adverse reaction reports of deaths to be much higher than monthly heartworm medications -- an average of 138 a year compared with as few as 6 for Heartgard and Sentinel.

Chief had tested positive for heartworms before receiving ProHeart 6 in May 2002.

Manufacturer Fort Dodge Animal Health has since strengthened label warnings against using the preventive on dogs already carrying the parasite.

During the past two years, the FDA has ordered three label changes and two "Dear Doctor" warning letters about possible adverse reactions.Experts say the concern is that the medication is a highly concentrated, microencapsulated drug that must be mixed in suspension for time release inside the animal's body. "[It] needs to be administered properly. It needs to be prepared properly," said Dr. Bert Childers, a veterinarian with the Society for the Prevention of Cruelty to Animals. Childershas used ProHeart 6 in the past without trouble, and still considers it safe. But his SPCA clinic does not dispense it, in favor of monthly treatment. "You can stop, and you don't have another 4 months left in the body that you have to contend with," he said. The company says dogs would be in greater danger missing heartworm treatment.

According to Fort Dodge, adverse reaction reports are less than one percent of more than 14 million doses given, and that most death reports are not actually proven to be from ProHeart 6.In fact, Sassy and Chief were cremated. Their owners can prove nothing with only their ashes. And both their veterinarians told them ProHeart 6 was not the cause. However, independent veterinarians told NBC 5 that the symptoms suggest otherwise.

"This is probably an adverse reaction from that," Childers said. "Stop the sale until they find out what's going on," Williams said. Meanwhile, the FDA says it is "actively" investigating. The FDA also recommends that pet owners should talk to their vet and read current warnings carefully before deciding which treatment to use.

For more information, or to report adverse reactions, please refer to the links below.

Resources

On The Net: FDA Veterinary Adverse Reaction Reporting
On The Net: Current ProHeart6 Product Label
On The Net: ProHeart6 FAQ
FDA-Required "Dear Doctor" Letters From Fort Dodge:

Letter 1 | Letter 2

On The Net: FDA ProHeart 6 Application Information
On The Net: FDA ProHeart6 Supplemental Information
On The Net: Heartworm Information

Pass this on to your family & friends & those that are important in your life"

.

.

.